Cerebrospinal fluid penetration of very high-dose meropenem: a case report.
Thomas KerzFriederike D von LoewenichJason RobertsAxel NeulenFlorian RingelPublished in: Annals of clinical microbiology and antimicrobials (2018)
High-dose meropenem can achieve CSF levels largely superior to those achieved with commonly recommended dosing regimens. Though our patient succumbed to an intracranial bleed which could be regarded as a severe adverse event, we suggest that meropenem dosing can be increased when pathogens with increased MICs are found in the CSF. More in vivo data are however needed to determine the safety of high-dose meropenem.